Protective effect of interferon type I on barrier function of human airway epithelium during rhinovirus infections in vitro
Open Access
- 16 December 2024
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-13
Abstract
The airway epithelium provides a crucial barrier against infection with respiratory pathogens. This barrier can be impaired following viral infection, paving the way for bacterial superinfections. Type I interferons (IFNs) are important antiviral mediators, and inhaled formulations of these glycoproteins are considered a potential approach for the treatment of respiratory viral infections. To investigate if type I IFNs can also protect against virus-induced epithelial barrier dysfunction, differentiated primary bronchial epithelial cells were pre-treated with IFN-β1a and subsequently infected with human rhinovirus (HRV) for 24 to 72h. Moreover, to functionally assess the effects of IFN-β1a pre-treatment on barrier integrity, we conducted co-infection experiments, in which cells were initially infected with HRV, and superinfected with Streptococcus pneumoniae 24 to 72 h later. In untreated cells, HRV infection significantly damaged ZO-1 positive tight junctions and cilia, and transiently increased permeability, whereas the barrier of cultures pre-treated with IFN-β1a remained intact. In co-infection experiments, bacteria were able to penetrate deeper into the cell layers of HRV-infected cultures than into those of uninfected cells. IFN-β1a pre-treatment abrogated virus-induced damage to the epithelial barrier. Taken together, these data demonstrate a beneficial effect of IFN-β in protecting epithelial barrier function in addition to its antiviral effects.Keywords
Funding Information
- Johann Wolfgang Goethe-Universität, Frankfurt am Main
This publication has 64 references indexed in Scilit:
- Antiviral activities of type I interferons to SARS-CoV-2 infectionAntiviral Research, 2020
- Shared and Distinct Functions of Type I and Type III InterferonsImmunity, 2019
- Phenotypic and genetic aspects of epithelial barrier function in asthmatic patientsJournal of Allergy and Clinical Immunology, 2017
- In vitro anti-influenza A activity of interferon (IFN)-λ1 combined with IFN-β or oseltamivir carboxylateAntiviral Research, 2014
- Epithelial barrier function: At the front line of asthma immunology and allergic airway inflammationJournal of Allergy and Clinical Immunology, 2014
- Exogenous IFN-β has antiviral and anti-inflammatory properties in primary bronchial epithelial cells from asthmatic subjects exposed to rhinovirusJournal of Allergy and Clinical Immunology, 2011
- Pattern Recognition Receptors and InflammationCell, 2010
- In vitro susceptibility to rhinovirus infection is greater for bronchial than for nasal airway epithelial cells in human subjectsJournal of Allergy and Clinical Immunology, 2009
- Pathogen Recognition and Innate ImmunityCell, 2006
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001